HIV Updates From CROI: The Good, the Bad, and the Long-Acting
On April 15, 2022, Treatment Action Group (TAG) presented “HIV Updates From CROI: The Good, the Bad, and the Long-Acting.” The free webinar unpacked the most significant developments in HIV research presented at the Conference on Retroviruses and Opportunistic Infections (CROI), held virtually on 12-16 and 22-24 February 2022, and what they mean for communities affected by HIV.
Speakers included David Ripin, Executive Vice President of Infectious Diseases at the Clinton Health Access Initiative (CHAI); Richard Jefferys, Basic Science, Vaccines and Cure Project Director at Treatment Action Group (TAG); Dedrick Tillerson, participant in the HIV Prevention Trials Network (HPTN); and Dr. Raphael J. Landowitz, MD, Professor of Medicine at UCLA Center for Clinical AIDS Research and Education. Following the presentations, participants had the opportunity to ask any questions they had about this year’s CROI, or related topics.
Recordings of the webinar are below, with audio in English, French, Spanish, and Portuguese.
Source: Treatment Action Group